Table of contents

Part I: Basic Principles

The Link Between Inflammation and Thrombosis - James de Lemos
The Platelet in Arterial and Venous Thrombosis - Edward F. Plow
The Coagulation Cascade in Arterial and Venous Thrombosis - Kandice Marchant
Genetics of Thrombosis - Marc S. Penn
Part II: Antithrombotic Therapy for Stable Coronary Atherosclerotic Disease

Aspirin for Primary and Secondary Prevention - Mike Lauer
Clopidogrel and Thienopyridines in Stable CAD Patients - Marcus Flather
Part III: Antithrombotic Therapy for NSTE ACS

Anti-platelet Therapies: Aspirin, Clopidogrel and Thienopyridines, and Glycoprotein IIb/IIIa Inhibitors - Deepak Bhatt
Unfractionated Heparin and Enoxaparin:. - Elliott M. Antman
The Direct Thrombin Inhibitors - A. Michael Lincoff
Synthetic Factor Xa Inhibition, Fondaparinux - Shamir Mehta
Part IV: Antithrombotic Therapy for STEMI

Antiplatelet Therapies: Aspirin, Clopidogrel and Thienopyridines, and Glycoprotein IIb/IIIa Inhibitors - Mark Sabatine
Antithrombin Therapies: Unfractionated Heparin, Enoxaparin, Fondaparinux - Arman T. Askari
Fibrinolysis and Facilitated PCI - Sorin J. Brener
Part V: Antithrombotic Therapy in Interventional Cardiology

Antithrombotic Therapy in Percutaneous Coronary Intervention - Adrian W. Messerli
Antithrombotic Therapy in Carotid and Peripheral Intervention - Samir Kapadia
Monitoring of Antithrombotic Therapies - Steve Steinhubl
Part VI: Antithrombotic Therapy in Venous Thromboembolic Disease

Antithrombotic Therapy for DVT/PE - John R. Bartholemew
Fibrinolysis for PE - Heather Gornik
Duration of Anticoagulation Following VTE - Samuel Goldhaber
Part VII: Clinical Considerations

Antithrombotic Therapy for Atrial Fibrillation - Allan Klein
Antithrombotic Therapy for Valvular Heart Disease- Brian Hoyt
Antithrombotic Therapy for Cardiomyopathy - Wilson Tang
Heparin-Induced Thrombocytopenia - Arman T. Askari
"Resistance" to Antiplatelet Therapies - Peter Berger